Veterinary and Comparative Oncology · 2009 · 19 citations · 26 references
MedicineOncologySurgeryChemotherapyOncologic SurgerySurgical OncologyChemotherapy Drug AdministrationSarcoma SurgerySoft Tissue SarcomasVeterinary ChemotherapyAnticancer ChemotherapyAntineoplastic Drug TherapyBiodegradable Delivery MaterialsBiodegradable Delivery PlatformsBiodegradable Delivery SystemsCanine Soft Tissue SarcomaLocal Tumor RecurrenceSoft Tissue Sarcoma Treatment
Abstract Nineteen dogs with histologically confirmed soft tissue sarcomas of the extremities were treated with a combination of marginal surgery and intra‐operative chemotherapy in the form of cisplatin in a biodegradable implant delivery system (Atrigel ® ; Atrix Laboratories, Fort Collins, Co, USA). None of the dogs had evidence of metastasis at time of treatment. The median dose of cisplatin was 52.1 mg/m 2 (mean 55.4 mg/m 2 , range 18.5–108.6 mg/m 2 ). Wound complications were noted in 16 dogs (84.2%). Median follow‐up time was 874 days (mean 777 days, range 125–1463 days). Nine dogs (47.3%) were alive at the time of analysis. Local recurrence occurred in three dogs (16.6%). The time to recurrence was 214, 264 and 874 days.
26
Histopathologic grading in spindle cell soft tissue sarcomas
Jean‐Michel Coindre, Nguyen Binh Bui, F. Bonichon et al. · Cancer · 1988 · 132 citations · Full text